Characterization of occult hepatitis B virus from blood donors carrying genotype A2 or genotype D strains

Journal of Hepatology

Volumn 49, Issue 4, 2008, Pages 537-547

  Candotti, Daniel ^a   Grabarczyk, Piotr ^b   Ghiazza, Paola ^c   Roig, Roberto ^d   Casamitjana, Natalia ^e   Iudicone, Paola ^f   Schmidt, Michael ^g   Bird, Arthur ^h   Crookes, Robert ⁱ   Brojer, Ewa ^b   Miceli, Michelina ^f   Amiri, Azin ^j   Li, Chengyao ^a,k   Allain, Jean Pierre ^j  

^a NHS BLOOD AND TRANSPLANT   (United Kingdom)

^b INSTITUTE OF HEMATOLOGY AND TRANSFUSION MEDICINE   (Poland)

^c Struttura di Qualificazione Biologica del Sangue   (Italy)

^d Centro Transfusion Comunidad Valencia   (Spain)

^e BANC DE SANG I TEIXITS   (Spain)

^f Azienda San Camillo Forlanini   (Italy)

^g GOETHE UNIVERSITY   (Germany)

^h Western Province Blood Transfusion Service   (South Africa)

ⁱ SOUTH AFRICAN NATIONAL BLOOD SERVICE   (South Africa)

^j UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^k SOUTHERN MEDICAL UNIVERSITY   (China)

more..

Author keywords

Blood donors; Europe; HBV; Occult HBV

Indexed keywords

EPITOPE; HEPATITIS B SURFACE ANTIGEN; VIRUS DNA;

ARTICLE; B LYMPHOCYTE; BLOOD DONOR; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; ITALY; NUCLEOTIDE SEQUENCE; POLAND; PRIORITY JOURNAL; VIRUS LOAD;

ADULT; AGED; BLOOD DONORS; DNA, VIRAL; EPITOPES; EUROPE; FEMALE; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; MALE; MIDDLE AGED; PREVALENCE; VIRAL ENVELOPE PROTEINS;

EID: 50549099351     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2008.04.017     Document Type: Article

References (32)

1. Allain J.-P. Occult hepatitis B virus infection: implications in transfusion. Vox Sang 86 (2004) 83-91
2. Brojer E., Grabarczyk P., Liszewski G., Mikulska M., Allain J.-P., Letowska M., et al. Characterization of HBV DNA+/HBsAg- blood donors in Poland identified by triplex NAT. Hepatology 44 (2006) 1666-1674
3. Rehermann B., Ferrari C., Pasquinelli C., and Chisari F.V. The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response. Nat Med 2 (1996) 1104-1108
4. Raimondo G., Pollicino T., Cacciola I., and Squadrito G. Occult hepatitis B virus infection. J Hepatol 46 (2007) 160-170
5. Allain J.-P., Reesink H.W., and Lucey C. A European perspective on the management of donors and units testing positive for hepatitis B virus DNA. Transfusion 46 (2006) 1256-1258
6. Allain J.-P. International collaborative study proposal for the characterization of occult hepatitis B virus infection identified by nucleic acid or anti-HBc screening. Vox Sang 92 (2007) 254-257
7. Koppelman M.H., Sjerps M.C., Reesink H.W., and Cuypers H.T. Evaluation of COBAS AmpliPrep nucleic acid extraction in conjunction with COBAS AmpliScreen HBV DNA, HCV RNA and HIV-1 RNA amplification and detection. Vox Sang 89 (2005) 193-200
8. Schmidt M.C., Nubling M., Scheiblauer H., Chudy M., Walch L.A., Seifried E., et al. Anti-HBc screening of blood donors: a comparison of nine anti-HBc tests. Vox Sang 91 (2006) 237-243
9. Sauleda S., Maymo R.M., Piron M., Candotti D., Allain J.-P., Hernandez J.M., et al. Serological and molecular markers of hepatitis B virus in Spanish blood donors: evidence of occult hepatitis B. Vox Sang 93 (2006) 63
10. Heyns A.D.P., Swanevelder J.P., Lelie P.N., Crookes R.L., and Busch M.P. The impact of individual donation NAT screening on blood safety. ISBT Science Series. Vox Sang (2006) 203-308
11. Zahn A., Li C., Danso K., Candotti D., Owusu-Ofori S., Temple J., et al. Molecular characterization of occult hepatitis B in genotype E-infected subjects. J Gen Virol 89 (2008) 409-418
12. Candotti D., Opare-Sem O., Rezvan H., Sarkodie F., and Allain J.-P. Molecular and serological characterization of hepatitis B virus in deferred Ghanaian blood donors with and without elevated alanine amino transferase. J Viral Hepat 13 (2006) 715-724
13. Abou-Jaoudé G., and Sureau C. Role of the antigenic loop of the hepatitis B virus envelope proteins in infectivity of Delta virus. J Virol 79 (2005) 10460-10466
14. Dzierzanowska-Fangrat K., Woynarowski M., Szczygielska I., Jozwiak P., Cielecka-Kuszyk J., Dzierzanowska D., et al. Hepatitis B virus genotypes in children with chronic hepatitis B in Poland. Eur J Gastroenterol Hepatol 18 (2006) 655-658
15. Bielawski K.P., Charmuszko U., Dybikowska A., Stalke P., and Podhajska A.J. Genetic variability of hepatitis B virus isolates in Poland. Virus Genes 33 (2006) 77-86
16. Bielawski K.P., Dybikowska A., Lisowska-Charmuszko U., Stalke P., Gregorowicz K., Trocha H., et al. Distribution of HBV genotypes and mutants among hepatitis B infected patients from northern Poland. Int J Mol Med 14 (2004) 301-304
17. Dal Molin G., Poli A., Croce L.S., D'Agaro P., Biagi C., Comar M., et al. Hepatitis B virus genotypes, core promoter variants, and precore stop codon variants in patients infected chronically in North-Eastern Italy. J Med Virol 78 (2006) 734-740
18. Medici M.C., Aloisi A., Martinelli M., Abelli L.A., Casula F., Valcavi P., et al. HBV genotypes and antiviral-resistant variants in HBV infected subjects in Northern Italy. New Microbiol 29 (2006) 63-67
19. Rodriguez-Frias F., Jardi R., Buti M., Schaper M., Hermosilla E., Valdes A., et al. Hepatitis B virus genotypes and G1896A precore mutation in 486 Spanish patients with acute and chronic HBV infection. J Viral Hepat 13 (2006) 343-350
20. Avellon A., and Echevarria J.M. Frequency of hepatitis B virus 'a' determinant variants in unselected Spanish chronic carriers. J Med Virol 78 (2006) 24-36
21. Chisari F.V., and Ferrari C. Hepatitis B virus immunopathogenesis. Annu Rev Immunol 13 (1995) 29-60
22. Westover K.M., and Hughes A.L. Evolution of cytotoxic T-lymphocyte epitopes in hepatitis B virus. Inf Gen Evol 7 (2007) 254-262
23. Scheiblauer H., Soboll H., and Nick S. Evaluation of CE-marked HBsAg assays with respect to clinical sensitivity, analytical sensitivity, and Hepatitis B virus mutant detection. J Med Virol 78 (2006) S66-S70
24. Hsu H.Y., Chang M.H., Liaw S.H., Ni Y.H., and Cheng H.L. Changes of hepatitis B surface antigen variants in carrier children before and after universal vaccination in Taiwan. Hepatology 30 (1999) 1312-1317
25. Coleman P.F., Chen Y.C.J., and Mushahwar I.K. Immunoassay detection of hepatitis B surface antigen mutants. J Med Virol 24 (1999) 19-24
26. Jolivet-Reynaud C., Lesénéchal M., O'Donne B., Becquart L., Foussadier A., Forge F., et al. Localization of hepatitis B surface antigen epitopes present on variants and specifically recognized by anti-hepatitis B surface antigen monoclonal antibodies. J Med Virol 65 (2001) 241-249
27. Carman W.F., Zanetti A.R., Karayiannis P., Waters J., Manzillo G., Tanzi E., et al. Vaccine-induced escape mutant of hepatitis B virus. Lancet 336 (1990) 325-329
28. Carman W.F., Owsianka A., Wallace L.A., Dow B.C., and Mutimer D.J. Antigenic characterization of pre- and post-liver transplant hepatitis B surface antigen sequences from patients treated with hepatitis B immune globulin. J Hepatol 31 (1999) 195-201
29. Bertoletti A., Costanzo A., Chisari F.V., Levrero M., Artini M., Sette A., et al. Cytotoxic T lymphocyte response to a wild-type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope. J Exp Med 180 (1994) 933-943
30. Pollicino T., Raffa G., Costantino L., Lisa A., Campello C., Squadrito G., et al. Molecular and functional analysis of occult hepatitis B virus isolates from patients with hepatocellular carcinoma. Hepatology 45 (2007) 277-285
31. Chaudhuri V., Tayal R., Nayak B., Kumar Acharya S., and Kumar Panda S. Occult hepatitis B virus infection in chronic liver disease: full-length genome and analysis of mutant surface promoter. Gastroenterology 127 (2004) 1356-1371
32. Ghiazza G.P., Cesale Ros E., Cornagliotto G., Demarin G., Demarchi G., Gariglio V., et al. HBV-DNA and HBcAb IgG in blood donor population. Vox Sanguinis 91 (2006) 51